U.S. Advanced Gastroenterology Devices Market

Market Outlook

By 2035, the U.S. Advanced Gastroenterology Devices Market is projected to reach approximately USD 48.55 billion, expanding at a CAGR of 9.35% during the forecast period 2026–2035. The market is estimated at USD 19.86 billion in 2025, with historical analysis covering 2021–2024. Values in this report are expressed in USD billions.

The market represents the higher-technology end of the U.S. gastroenterology device ecosystem and includes advanced endoscopy platforms, therapeutic endoscopic instruments, endoscopic ultrasound systems, ERCP technologies, capsule endoscopy, artificial intelligence-assisted visualization, tissue resection and closure systems, endoscopic bariatric devices, hemostasis products, single-use scopes, advanced energy devices, and related procedural technologies. The market definition intentionally emphasizes technologies that materially improve visualization, intervention, diagnostic precision, or procedural efficiency rather than routine low-value gastrointestinal consumables.

Demand is supported by the exceptionally broad burden of digestive disease in the United States. Public-health estimates indicate that digestive diseases collectively affect approximately 60–70 million Americans. Gastroesophageal reflux disease alone affects roughly one-fifth of the U.S. population, while inflammatory bowel disease affects an estimated 2.4–3.1 million people. Gallstones affect approximately 10%–15% of Americans, representing nearly 25 million people. These conditions create recurring demand across upper GI endoscopy, colonoscopy, EUS, ERCP, capsule diagnostics, therapeutic intervention, tissue sampling, dilation, stenting, hemostasis, and long-term surveillance.

The addressable population is also expanding because U.S. healthcare is becoming older and more metabolically complex. The country had approximately 61.2 million people aged 65 years and older in 2024, equivalent to about 18% of the population. At the same time, adult obesity prevalence remains above 40%. These demographic factors increase the incidence or clinical complexity of colorectal neoplasia, GERD, Barrett’s esophagus, pancreaticobiliary disorders, GI bleeding, metabolic disease, and several conditions requiring recurring gastroenterology evaluation.

Colorectal cancer remains a particularly important procedural demand driver. Approximately 159,000 new U.S. colorectal cancer cases are expected in 2026. Screening recommendations beginning at age 45 have widened the eligible population for screening, although screening penetration remains incomplete. This creates a long-duration procedural opportunity for colonoscopy, advanced visualization, polypectomy, endoscopic mucosal resection, lesion characterization, computer-aided detection, and surveillance technologies.

Historically, the modeled market increased from approximately USD 13.90 billion in 2021 to USD 18.17 billion in 2024, reflecting normalization of elective endoscopy after pandemic-related disruption, replacement of aging endoscopy towers, adoption of high-definition and enhanced imaging, increased use of disposable accessories, recovery of colorectal screening volumes, and growth in complex therapeutic procedures. The market subsequently reached approximately USD 19.86 billion in 2025 as procurement increasingly shifted toward digitally integrated endoscopy platforms, AI-enabled colonoscopy, EUS-guided intervention, advanced closure technologies, single-use systems, and endoscopic metabolic therapies.

The strategic character of the market is changing. Historically, gastroenterology capital procurement was heavily centered on endoscope image quality, processor compatibility, physician familiarity, and acquisition price. By 2025, U.S. health systems were increasingly assessing the entire procedure ecosystem: lesion detection performance, turnover time, reprocessing burden, device-related infection risk, compatibility of therapeutic instruments, artificial intelligence capability, documentation workflow, service contracts, training requirements, and revenue capture per procedure room.

This shift favors manufacturers capable of building integrated platforms rather than isolated products. The companies positioned to outperform through 2035 will increasingly compete on the ability to help gastroenterologists detect disease earlier, perform more therapy during the index procedure, avoid surgery where clinically appropriate, improve room utilization, and support expansion into ambulatory settings.

Introduction

According to the U.S. Advanced Gastroenterology Devices Market Report, the industry sits at the intersection of high procedural volume, chronic disease management, cancer prevention, medical imaging, minimally invasive intervention, outpatient care migration, and digital decision support.

Gastroenterology is particularly attractive from a medical device perspective because a diagnostic procedure can rapidly become therapeutic. A routine colonoscopy may require polypectomy, clipping, injection, ablation, or advanced resection. Upper endoscopy can progress to dilation, hemostasis, tissue acquisition, stent placement, mucosal therapy, or closure. EUS can combine imaging with fine-needle biopsy, drainage, therapeutic access, or interventional procedures. ERCP combines visualization, access, guidewire technology, sphincterotomy, stone extraction, dilation, stenting, and drainage within a single episode.

This procedure intensity creates recurring revenue opportunities beyond the installed base of scopes and processors. Every advanced endoscopy room can generate demand for snares, forceps, needles, clips, guidewires, balloons, stents, catheters, retrieval devices, energy instruments, closure systems, biopsy products, infection-control components, and software.

The market also benefits from a major change in the philosophy of gastrointestinal care. Rather than referring every complex lesion or anatomical problem to surgery, advanced endoscopists can increasingly treat selected patients using endoscopic mucosal resection, endoscopic submucosal dissection, full-thickness closure, endoscopic suturing, EUS-guided drainage, advanced biliary access, endoscopic bariatric procedures, and other minimally invasive techniques.

This shift has important economic consequences. Avoiding an operating-room episode can reduce surgical resource use, inpatient bed utilization, recovery requirements, and downstream complications. For hospitals, advanced gastroenterology programs can therefore protect procedural revenue while simultaneously supporting less-invasive care. For ambulatory providers, technologies that enable safe and efficient treatment outside the hospital can expand the range of commercially attractive procedures.

From 2026 through 2035, the competitive frontier is expected to move toward intelligent therapeutic endoscopy: endoscopy systems capable of combining enhanced visualization, artificial intelligence, precise tissue characterization, advanced intervention, automated documentation, and longitudinal data. The strategic advantage will increasingly belong to device manufacturers that control multiple points in this workflow.

Key Market Drivers: What Is Fueling the U.S. Advanced Gastroenterology Devices Market?

The first major driver is the scale and diversity of U.S. digestive disease. Unlike device markets dependent on a narrow patient group, gastroenterology spans chronic reflux, colorectal cancer prevention, inflammatory bowel disease, GI bleeding, pancreatic disease, biliary disease, obesity, swallowing disorders, Barrett’s esophagus, liver-related complications, gastrointestinal tumors, and small-bowel disease. Approximately 60–70 million Americans are affected by digestive diseases, supporting one of the broadest recurring procedural pools in U.S. specialty medicine.

A second driver is the expansion of colorectal screening and surveillance. U.S. screening recommendations generally begin at age 45 for average-risk adults, substantially broadening the eligible screening population compared with the previous age-50 threshold. Roughly seven in ten adults aged 50–75 are up to date with recommended colorectal cancer screening, indicating that a meaningful screening gap remains. At the same time, colorectal cancer incidence among younger adults has become a greater clinical concern. These factors support sustained colonoscopy demand and make improvements in adenoma recognition, lesion characterization, resection, and workflow productivity economically valuable.

A third driver is the increasing therapeutic capability of endoscopy. Advanced gastroenterologists can perform procedures that historically required surgery or interventional radiology. Endoscopic mucosal resection, submucosal dissection, suturing, full-thickness defect closure, endoscopic bariatric intervention, EUS-guided drainage, complex ERCP, luminal stenting, and advanced hemostasis expand the value generated from each endoscopy suite. This changes the purchasing logic from “scope acquisition” toward development of a comprehensive interventional platform.

A fourth driver is AI-assisted lesion detection and characterization. Artificial intelligence is becoming an embedded layer in advanced gastroenterology rather than a stand-alone software category. Computer-aided detection during colonoscopy can draw attention to suspected mucosal abnormalities in real time, while new algorithms are moving toward lesion characterization, procedure quality measurement, report automation, and capsule endoscopy review. For health systems, the long-term value proposition extends beyond detection performance to standardization of quality between physicians and sites.

A fifth driver is migration toward ambulatory care. Gastroenterology already has a substantial outpatient procedural footprint, particularly for colonoscopy and upper GI endoscopy. As payers and health systems seek lower-cost sites of care, freestanding endoscopy centers and ambulatory surgery centers are becoming increasingly important purchasers. Devices that offer fast setup, predictable service requirements, simplified infection control, compact footprints, and reduced capital intensity are particularly well aligned with this shift.

The sixth driver is U.S. obesity and metabolic disease. Adult obesity prevalence remains approximately 40%, providing a substantial potential population for endoscopic metabolic and bariatric intervention. Although pharmacologic obesity therapy has changed treatment pathways, it has not eliminated the role of procedural therapy. Instead, it is likely to encourage a more segmented market in which gastroenterologists combine medication, endoscopic intervention, nutrition, and longitudinal metabolic management according to patient response and disease severity.

A seventh driver is hospital focus on infection prevention and reprocessing economics. Reusable flexible endoscopy requires specialized cleaning, disinfection, drying, storage, tracking, quality control, and trained staff. Concerns regarding cross-contamination have increased strategic interest in disposable components and single-use endoscopes for selected procedures. The economic decision is not simply reusable versus disposable device price; hospitals increasingly analyze reprocessing labor, repair cost, downtime, procedure cancellations, infection risk, and utilization intensity.

Finally, the market is supported by a strong U.S. regulatory and clinical innovation ecosystem. FDA clearances in AI-assisted gastroenterology, capsule endoscopy, endoscopic suturing, advanced imaging, endoscopic ultrasound, and single-use endoscopy demonstrate continued product turnover. Academic medical centers frequently act as early adoption sites, training centers, trial investigators, and referral hubs before technologies penetrate community hospitals and ambulatory centers.

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in advanced gastroenterology is moving from incremental improvements in endoscope hardware toward integrated procedural intelligence.

Enhanced visualization remains foundational. High-definition and 4K imaging, narrow-band or wavelength-specific imaging, improved illumination, electronic chromoendoscopy, larger fields of view, and improved image processing can help clinicians evaluate subtle mucosal abnormalities. As imaging quality becomes more standardized across premium systems, differentiation is increasingly moving into workflow integration and software intelligence.

Artificial intelligence represents the most visible change. FDA-regulated gastrointestinal lesion detection systems can analyze colonoscopy images in real time and alert clinicians to suspected abnormalities. AI is also entering capsule endoscopy, where reviewing large volumes of recorded images has historically been time intensive. Over the forecast period, the commercially important shift will be from isolated detection algorithms toward platforms that assist detection, classification, documentation, quality measurement, and patient follow-up.

Therapeutic tissue management is undergoing equally important innovation. Improved endoscopic suturing and tissue approximation devices allow physicians to close defects, manage fistulas, revise anatomy, and perform advanced bariatric procedures. Endoscopic clips, over-the-scope closure systems, hemostatic technologies, suturing platforms, and full-thickness devices are increasingly relevant as resection procedures become more ambitious.

EUS is evolving from a diagnostic modality into an interventional platform. Advanced EUS can support tissue sampling, pseudocyst drainage, gallbladder drainage in selected patients, biliary access, pancreatic intervention, and other highly specialized procedures. This transition raises the value of EUS systems, access devices, biopsy needles, guidewires, stents, and drainage technologies.

Capsule endoscopy is also becoming more digitally sophisticated. Cloud-enabled image review, improved battery and imaging performance, AI-assisted analysis, and streamlined data handling can improve physician productivity. Capsule technology is particularly important for small-bowel evaluation, obscure GI bleeding, and selected inflammatory disease pathways.

Robotic and computer-assisted endoluminal systems remain an emerging frontier. Commercial adoption is still early compared with conventional flexible endoscopy, but the underlying rationale is strong: improved instrument stability, better triangulation, greater control of complex therapeutic procedures, and potential expansion of procedures currently restricted to highly experienced operators. Through 2035, robotics is likely to create a premium niche rather than replace conventional endoscopy.

Segmentation Insights

The U.S. Advanced Gastroenterology Devices Market is segmented on the basis of product category, application, end user, technology type, and region.

By Product Category

Advanced Endoscopy and Visualization Systems

Advanced endoscopy and visualization systems represent the core capital-equipment layer of the market. The segment includes high-definition and 4K processors, flexible gastroscopes and colonoscopes, advanced imaging platforms, endoscopic ultrasound systems, specialized therapeutic scopes, light sources, display systems, and related hardware. Revenue is supported by installed-base replacement, technology refresh cycles, service contracts, and health-system standardization.

Premium systems increasingly compete on more than image resolution. U.S. health systems evaluate compatibility with artificial intelligence, therapeutic accessories, information systems, reprocessing infrastructure, service response, physician preference, and total ownership cost. Large integrated delivery networks can therefore create substantial winner-takes-more procurement opportunities when they standardize an endoscopy platform across multiple facilities.

Therapeutic Endoscopy and Tissue Management Devices

This category includes snares, clips, suturing systems, tissue approximation devices, resection instruments, dilation systems, hemostasis products, injection needles, ablation technologies, retrieval devices, and endoscopic closure tools. It is one of the most strategically attractive categories because most products generate recurring per-procedure revenue.

Growth is being strengthened by increasing adoption of endoscopic mucosal resection, advanced polypectomy, defect closure, minimally invasive management of GI bleeding, and procedures designed to avoid surgery. Manufacturers that combine reliable device performance with strong clinical education have an advantage because advanced therapeutic techniques are operator dependent.

EUS, ERCP and Pancreatobiliary Devices

The EUS and ERCP segment includes echoendoscopes, ultrasound processors, fine-needle aspiration and biopsy devices, sphincterotomes, guidewires, extraction balloons, baskets, dilation devices, biliary and pancreatic stents, drainage technologies, and advanced access systems.

This is a high-value specialist market concentrated in hospitals, academic centers, and major referral practices. Growth comes from pancreatic and biliary disease, cancer diagnosis, tissue acquisition, stone disease, complex strictures, and the expanding therapeutic role of EUS. Device selection is highly influenced by advanced endoscopist preference, technical performance, and procedure-specific evidence.

Capsule and Single-Use Endoscopy Devices

Capsule and single-use endoscopy includes ingestible imaging capsules, capsule-reading software, cloud-enabled review platforms, disposable gastroscopes or specialized endoscopes, and related accessories.

Capsule systems benefit from continued demand for noninvasive small-bowel visualization and improvements in software-assisted interpretation. Single-use endoscopy is driven by infection control, elimination of reprocessing, predictable availability, and reduced repair requirements. Cost-per-case remains an adoption constraint in high-volume routine procedures, making the strongest near-term opportunities procedure- and facility-specific.

Endoscopic Bariatric, Metabolic and Advanced Closure Devices

This segment includes endoscopic suturing systems, gastric remodeling technologies, intragastric devices, tissue approximation products, incisionless reflux-related systems, and other technologies designed to alter gastrointestinal anatomy without conventional surgery.

The addressable clinical need is significant given U.S. obesity prevalence above 40%. Growth, however, depends on reimbursement, physician training, comparative outcomes, durability, competition with pharmacotherapy, and development of multidisciplinary obesity programs. Manufacturers able to position devices as part of a longitudinal metabolic-care pathway rather than a stand-alone procedure are likely to achieve stronger utilization.

By Application

Colorectal Cancer Screening, Polyp Detection and Resection

Colorectal screening is the largest recurring application for advanced gastroenterology devices. Colonoscopy combines high procedure volume with repeated use of imaging, insufflation, snares, forceps, injection devices, clips, retrieval systems, pathology-related accessories, and increasingly AI-assisted detection.

Approximately 159,000 U.S. colorectal cancer cases are expected in 2026, reinforcing the importance of prevention and early detection. Commercial growth is increasingly shifting toward improved lesion recognition, complex polypectomy, mucosal resection, AI-assisted quality improvement, and more efficient endoscopy-center workflow rather than basic colonoscope penetration alone.

Upper Gastrointestinal Disease, GERD and Barrett’s Esophagus

Upper GI applications include GERD evaluation, dysphagia, ulcers, GI bleeding, Barrett’s esophagus, upper GI tumors, strictures, and other esophageal or gastric disorders. GERD affects approximately one in five Americans, creating a substantial diagnostic population.

Advanced opportunities include enhanced mucosal imaging, tissue sampling, dilation, hemostasis, ablation, endoscopic anti-reflux interventions, suturing, and surveillance of patients with premalignant conditions. Hospitals with multidisciplinary esophageal programs represent particularly attractive targets for premium technologies.

Pancreatic, Biliary and Hepatobiliary Disorders

This application category generates disproportionately high device value because cases frequently involve ERCP, EUS, tissue acquisition, guidewires, stents, drainage, stone extraction, or several devices within one procedure.

Gallstones alone affect approximately 10%–15% of the U.S. population. Pancreatic cancer evaluation, obstructive disease, strictures, pancreatitis, biliary stones, and complex postoperative anatomy also create demand. High technical complexity gives specialist physicians substantial influence over vendor selection.

Inflammatory Bowel Disease, Small-Bowel Disease and GI Bleeding

An estimated 2.4–3.1 million Americans have inflammatory bowel disease. These patients may undergo recurring colonoscopy, disease surveillance, mucosal assessment, biopsy, stricture evaluation, and small-bowel investigation.

Capsule endoscopy has an important position in small-bowel evaluation, while advanced imaging can improve assessment of mucosal disease activity. GI bleeding additionally supports demand for clips, coagulation devices, injection products, hemostatic agents, capsule technology, enteroscopy accessories, and advanced diagnostic procedures.

Obesity and Metabolic Gastroenterology

Obesity-related gastroenterology is emerging as an important growth application as GI practices build endoscopic bariatric and metabolic programs. More than four in ten U.S. adults meet the clinical definition of obesity based on recent national measured data.

The segment must coexist with bariatric surgery and highly effective anti-obesity medicines. Its opportunity therefore lies in patients who need an option between pharmacologic therapy and conventional surgery, patients requiring combination therapy, and selected patients who prefer minimally invasive procedural treatment.

By End User

Hospitals and Integrated Health Systems

Hospitals represent the largest end-user segment by market value because they perform complex EUS, ERCP, advanced resection, GI bleeding management, therapeutic interventions, inpatient endoscopy, and procedures requiring anesthesia, surgery, radiology, or intensive support.

Large integrated delivery networks increasingly centralize capital procurement and negotiate enterprise contracts. Vendors must therefore sell to both clinicians and value-analysis teams. Clinical preference remains essential, but purchasing decisions increasingly incorporate device standardization, service levels, reprocessing infrastructure, procedure economics, and systemwide contracting.

Ambulatory Surgery Centers

ASCs are a major growth channel for colonoscopy, upper GI endoscopy, polypectomy, biopsy, and selected therapeutic procedures. Their purchasing model is different from hospitals because they operate with tighter per-case economics and place greater emphasis on throughput.

Compact systems, predictable service expense, rapid room turnover, efficient consumables, and technologies that can increase procedural quality without materially increasing labor are well suited to this environment. Expansion of ASC gastroenterology capacity will increase price competition but also enlarge the addressable device installed base.

Gastroenterology Practices and Freestanding Endoscopy Centers

Independent and multisite GI groups are increasingly sophisticated device buyers. Consolidation of physician practices has created organizations with sufficient scale to negotiate equipment, accessories, software, and service contracts across multiple endoscopy facilities.

These purchasers tend to prioritize procedure-room utilization, reimbursement capture, physician satisfaction, scheduling efficiency, and total cost per case. AI-assisted detection and cloud-based technology can be particularly attractive when deployable across an entire practice network.

Academic Medical Centers and Advanced GI Referral Centers

Academic and tertiary referral centers represent a smaller portion of procedure volume but exert disproportionate influence on technology adoption. Complex ESD, EUS intervention, difficult ERCP, endoscopic suturing, bariatric endoscopy, and experimental robotic procedures are more likely to penetrate these institutions first.

Manufacturers benefit from collaboration with these centers through evidence generation, training, investigator relationships, fellowship exposure, and physician-to-physician education. Technology adopted successfully at leading centers can subsequently migrate into regional hospitals.

Specialty Clinics and Other Care Settings

Smaller specialty clinics, pediatric GI centers, obesity centers, and selected outpatient facilities form a fragmented but growing end-user category. Products suited to this market generally require limited capital infrastructure and simple operational deployment.

Single-use scopes, capsule endoscopy, compact diagnostic platforms, and software-enabled technologies can benefit as advanced gastroenterology becomes less dependent on large hospital campuses.

By Technology Type

HD, 4K and Advanced Optical Imaging

Advanced optical imaging remains the largest technology foundation. Continuous improvements in image processing, illumination, visualization of mucosal and vascular patterns, and digital enhancement support lesion detection and characterization.

The commercial challenge is increasing commoditization of basic high-definition visualization. Future premium differentiation will depend more on clinical software, intelligent image processing, therapeutic integration, and procedural workflow.

Artificial Intelligence and Software-Assisted Endoscopy

AI is expected to be one of the fastest-growing technology categories through 2035. FDA-cleared gastrointestinal lesion detection products have already established the regulatory pathway for computer-assisted endoscopic detection.

The next competitive phase will involve richer clinical functionality: lesion characterization, automated quality metrics, procedure documentation, capsule triage, prediction tools, and longitudinal analytics. Hospitals will increasingly demand interoperability rather than isolated AI boxes.

Robotic, Navigational and Computer-Assisted Endoscopy

Robotic and computer-assisted technologies remain relatively early but offer long-term upside in technically difficult therapeutic procedures. Improved stability, instrument control, navigation, and multi-instrument manipulation could make some procedures more standardized.

The principal barriers are capital cost, training, procedure time, reimbursement, and the need to demonstrate advantages over highly skilled manual endoscopy. Adoption is therefore expected to begin at tertiary centers.

Single-Use and Disposable Technology

Single-use technology addresses reprocessing complexity and contamination risk. Its strongest commercial proposition exists where reusable equipment has high repair burden, urgent availability is important, procedure volume is limited, or difficult-to-clean device architecture increases operational complexity.

Procurement decisions will remain highly economic. Facilities with extremely high utilization can continue to achieve favorable reusable-device economics, while single-use models can be compelling for selected procedures and sites.

Advanced Energy, Suturing, Closure and Tissue-Resection Technology

Advanced therapeutic technology is enabling gastroenterologists to perform increasingly complex interventions without open or laparoscopic surgery. Energy platforms, endoscopic suturing, clips, tissue approximation, resection systems, and defect closure tools are becoming central to advanced GI programs.

This category has strong growth potential because it directly expands what can be treated during endoscopy. Successful companies will need not only differentiated devices but also robust physician-training infrastructure.

Regional Insights: Where the Market Is Growing Fastest

The U.S. Advanced Gastroenterology Devices Market is segmented geographically into the South, Northeast, West, and Midwest. Regional market performance is determined by population scale, age profile, colorectal screening volumes, obesity prevalence, hospital and ASC density, concentration of advanced gastroenterologists, academic referral networks, payer mix, and speed of technology adoption.

The South is estimated to represent the largest regional market at approximately USD 6.85 billion in 2025, while the West is expected to generate the fastest growth through 2035. The Northeast remains a disproportionately important market for complex therapeutic procedures and early clinical adoption, while the Midwest provides a large, mature base of hospital and community gastroenterology demand.

South

The South represented an estimated USD 6.85 billion in 2025, making it the largest U.S. regional market. The region includes Texas, Florida, Georgia, North Carolina, South Carolina, Virginia, West Virginia, Maryland, Delaware, Kentucky, Tennessee, Alabama, Mississippi, Louisiana, Arkansas, Oklahoma and the District of Columbia, depending on market-region convention.

Its leadership reflects rapid population growth, large Medicare populations, high metabolic disease burden, strong hospital expansion, growing ASC capacity, and large colorectal screening populations.

Texas is one of the most commercially important states. Houston, Dallas-Fort Worth, Austin, and San Antonio contain major hospital networks, academic centers, large GI practices, and substantial ASC infrastructure. The state is important for advanced colonoscopy, therapeutic endoscopy, ERCP, EUS, bariatric endoscopy, and practice-level procurement.

Florida has a particularly favorable demographic profile for gastroenterology devices because of its large older population. Screening, surveillance colonoscopy, pancreaticobiliary disease management, GI bleeding, and cancer-related procedures generate significant procedural intensity. Consolidated physician groups and ambulatory endoscopy facilities also make Florida an attractive market for enterprise deployments.

North Carolina, Georgia, Tennessee and Virginia are increasingly important advanced-GI markets because of population migration, hospital investment, specialty-care expansion, and major academic referral programs. Large health systems in these states can act as regional reference accounts for premium endoscopic technologies.

Alabama, Mississippi, Louisiana, Arkansas, Kentucky, Oklahoma and West Virginia have substantial digestive and metabolic disease burdens but uneven access to advanced GI specialists. This creates two different commercial opportunities: high-value intervention platforms concentrated at regional medical centers and scalable diagnostic or ambulatory technologies in community markets.

Under the current market model, the South could approach USD 16.78 billion by 2035, maintaining regional leadership.

West

The West represented approximately USD 4.67 billion in 2025 and is expected to be the fastest-growing regional market through 2035. It includes California, Washington, Oregon, Arizona, Nevada, Colorado, Utah, New Mexico, Idaho, Montana, Wyoming, Alaska and Hawaii.

California is the dominant state market in the West. It combines a very large patient population with nationally recognized academic hospitals, sophisticated integrated health systems, medical-device innovation, digital-health adoption, and large multisite GI practices. AI-assisted colonoscopy, advanced visualization, EUS, endoscopic bariatric therapy, robotic systems, and advanced resection technologies are likely to achieve earlier adoption in California than in many less innovation-intensive markets.

Arizona and Nevada benefit from fast population growth and substantial retiree populations. Expansion of hospital systems and outpatient specialty capacity supports increasing demand for colonoscopy, EUS, ERCP and advanced therapeutic technologies.

Washington, Oregon, Colorado and Utah have strong integrated delivery networks and digitally sophisticated provider environments. These states are attractive for AI, connected workflow, cloud-enabled capsule endoscopy, quality analytics, and enterprise technology deployment.

Smaller Western markets including Idaho, Montana, Wyoming, Alaska and Hawaii are more constrained by specialist density and geographic access. Technologies that reduce the requirement for centralized infrastructure or facilitate remote interpretation can have comparatively greater strategic relevance.

The West is projected to approach approximately USD 12.13 billion by 2035, gradually increasing its national share.

Northeast

The Northeast accounted for an estimated USD 4.94 billion in 2025. The region includes New York, Pennsylvania, New Jersey, Massachusetts, Connecticut, Rhode Island, Vermont, New Hampshire and Maine.

The region has one of the highest concentrations of academic hospitals, tertiary GI programs, fellowship-trained advanced endoscopists, cancer centers, and sophisticated hospital procurement organizations in the country.

New York is the largest state opportunity, supported by dense population centers, major health systems, academic institutions, and high procedure volumes. Complex therapeutic endoscopy, pancreaticobiliary intervention, advanced resection and AI-enabled imaging are particularly relevant.

Massachusetts has a smaller population but outsized influence on clinical innovation. Boston’s concentration of academic medicine, biotechnology, medical-device companies, and clinical research makes the state strategically important for technology launches and physician advocacy.

Pennsylvania and New Jersey provide large community and hospital procedure bases, while Connecticut also supports advanced GI programs linked to major regional referral networks.

New England states with smaller populations have lower absolute device demand but can still support premium technology at major academic and regional centers. Procurement tends to be evidence intensive, requiring strong clinical data, workflow justification, and service support.

The Northeast is projected to reach approximately USD 11.70 billion by 2035. Growth is likely to trail the West slightly because the region is more mature, but premium technology penetration will remain high.

Midwest

The Midwest represented approximately USD 3.40 billion in 2025. The region includes Illinois, Ohio, Michigan, Indiana, Wisconsin, Minnesota, Missouri, Iowa, Kansas, Nebraska, North Dakota and South Dakota.

The regional market is supported by mature hospital networks, high colorectal screening demand, major academic systems, community GI practices, and strong procedural referral networks.

Illinois benefits from the large Chicago healthcare market, which includes major academic centers, integrated health systems, independent gastroenterology networks, and ambulatory facilities.

Ohio and Michigan are major hospital-driven markets with significant digestive disease and cancer-management infrastructure. Cleveland, Columbus, Cincinnati, Detroit, and other major metropolitan areas support high volumes of colonoscopy, upper GI procedures, EUS, ERCP and therapeutic endoscopy.

Minnesota is strategically important due to its medical-technology ecosystem and concentration of high-acuity specialty care. It can function as both a technology-development and clinical-adoption market.

Indiana, Wisconsin, Missouri, Iowa and Kansas generate stable procedural demand and are particularly relevant for manufacturers seeking expansion across community hospitals and multisite GI groups. Nebraska, North Dakota and South Dakota are smaller but can benefit from referral-based care networks and technologies that facilitate access.

The Midwest is projected to reach approximately USD 7.94 billion by 2035. Growth should remain durable, although population expansion and technology adoption are expected to be less aggressive than in the South and West.

Key Market Players

The U.S. Advanced Gastroenterology Devices competitive landscape combines large multinational endoscopy-platform manufacturers with specialized companies in therapeutic endoscopy, AI, capsule imaging, single-use technology, tissue closure, bariatric intervention, and pancreatobiliary devices.

Competition is increasingly ecosystem based. Leading companies can combine capital equipment, disposable instruments, clinical training, software, service contracts, and hospital-level contracting. Smaller specialists can nevertheless capture substantial value when they solve a difficult procedural problem or establish a strong clinical position within advanced endoscopy.

Some of the key players operating in the U.S. Advanced Gastroenterology Devices industry include:

Olympus Corporation
Boston Scientific Corporation
Medtronic
FUJIFILM Healthcare Americas Corporation
PENTAX Medical / HOYA Corporation
STERIS
Cook Medical
CONMED Corporation
Ambu A/S
KARL STORZ
ERBE USA
B. Braun
Micro-Tech Endoscopy USA
Ovesco Endoscopy USA
Merit Medical Systems
EvoEndo
EndoGastric Solutions
CapsoVision
AnX Robotica
Creo Medical
Laborie Medical Technologies
Endo Tools Therapeutics
Cosmo Pharmaceuticals / Cosmo Intelligent Medical Devices
Envision Endoscopy

Olympus, Boston Scientific, Medtronic and Fujifilm have particularly strong strategic positions because they participate across major portions of the endoscopy, therapeutic GI, visualization, pancreaticobiliary, capsule, or AI ecosystem. PENTAX Medical remains an important flexible-endoscopy competitor, while Ambu and EvoEndo illustrate the strategic expansion of single-use approaches.

STERIS is highly relevant because infection prevention, reprocessing and endoscopy workflow are integral to the economics of reusable endoscopy. Cook Medical, Micro-Tech Endoscopy, Ovesco, ERBE, CONMED, Merit Medical and B. Braun compete across therapeutic accessories, hemostasis, resection, closure, energy, access, drainage and related procedural categories.

Competition through 2035 will be shaped by FDA clearance velocity, clinical evidence, installed-base compatibility, physician training, service quality, product availability, hospital contracting, AI integration, procedural efficiency, and the ability to prove economic value. Manufacturers that improve both clinical capability and procedure-room productivity will have the strongest position to defend premium pricing.

Recent Developments

Recent U.S. regulatory activity demonstrates how quickly the advanced gastroenterology technology stack is evolving.

In January 2024, FDA clearance activity involving updated GI Genius computer-aided detection modules and ColonPRO software reinforced the commercial development of AI-assisted colonoscopy. AI is increasingly moving from novel add-on technology toward a component of premium endoscopy-platform differentiation.

In May 2024, the PillCam Genius SB System, including associated software and cloud-reader capabilities, received U.S. 510(k) clearance. This development demonstrates the increasing importance of digital workflow and remote software infrastructure in capsule endoscopy.

In April 2025, the SimpleStitch Suturing System received 510(k) clearance as an endoscopic tissue approximation device. Advances in tissue approximation are strategically important because endoscopic closure and suturing can broaden the range of therapeutic procedures performed without conventional surgery.

In June 2025, the EvoEndo Single-Use Endoscopy System received FDA 510(k) clearance. Single-use endoscopy remains a strategically important technology area because it challenges the traditional reusable-device economics of reprocessing, infection prevention, repair, and equipment availability.

In October 2025, the Olympus GF-UE190 gastrointestinal endoscopic ultrasound videoscope received U.S. 510(k) clearance. The development is consistent with the continuing transition of EUS from primarily diagnostic imaging toward a broader interventional platform.

During February 2026, the Endomina EZFuse system received 510(k) clearance as an endoscopic tissue approximation device. Continued regulatory activity in this category supports the emergence of more sophisticated endoscopic suturing, closure, and metabolic procedures.

In March 2026, FDA clearance of Deep Capsule, gastrointestinal capsule endoscopy analysis software using advanced algorithmic analysis, demonstrated the continued movement of AI beyond conventional colonoscopy and into image-intensive capsule review.

In June 2026, Boston Scientific’s RIVOS EUS Access Device received 510(k) clearance, reinforcing ongoing innovation around endoscopic ultrasound access and intervention.

Together, these developments indicate that the next competitive cycle in U.S. gastroenterology will not be defined by a single device architecture. Growth is occurring simultaneously across imaging, artificial intelligence, EUS, single-use systems, capsule diagnostics, tissue approximation, and advanced therapeutic access.

Conclusion

The U.S. Advanced Gastroenterology Devices Market Size & Share is projected to expand from approximately USD 19.86 billion in 2025 to USD 48.55 billion by 2035, representing a CAGR of 9.35% during 2026–2035.

The market’s long-term strength derives from a combination of high digestive disease prevalence, population aging, persistent colorectal screening requirements, increasing therapeutic capability of endoscopy, obesity-related care demand, outpatient procedure migration, and rapid development of AI-assisted clinical workflows.

The most attractive value pools are expected to develop in AI-enabled endoscopy, advanced therapeutic tissue management, EUS-guided intervention, ERCP and pancreaticobiliary technology, endoscopic suturing and closure, capsule endoscopy, advanced optical imaging, single-use endoscopy, and endoscopic metabolic therapy.

Traditional endoscopy platforms will remain essential, but hardware alone will become increasingly difficult to differentiate. Competitive advantage will move toward integrated systems that combine superior visualization, intelligent detection, therapeutic capability, procedural data, service infrastructure, and clinical education.

Hospital procurement will consequently become more sophisticated. Health systems will increasingly ask whether a new technology can increase case throughput, eliminate repeat procedures, enable care migration, reduce reprocessing or repair burden, improve lesion detection, avoid surgery, standardize quality, and create measurable clinical or economic benefit.

Regional opportunity will remain strongest in the South, led particularly by Texas and Florida, while the West is expected to record the fastest growth due to population expansion and faster adoption of digitally enabled technologies. The Northeast will continue to exert disproportionate influence on premium therapeutic innovation and clinical evidence, while the Midwest will provide durable demand from mature hospital and community gastroenterology networks.

For manufacturers, investors, distributors, hospital strategy teams, and other clients evaluating the market, the central question is therefore not whether U.S. gastroenterology device spending will grow. The more important issue is where incremental value will move as gastroenterology evolves from diagnostic endoscopy toward intelligent, image-guided, minimally invasive therapy.

Companies that successfully combine procedural innovation, workflow economics, physician adoption, regulatory execution, reimbursement awareness, AI integration, and evidence generation will be best positioned to capture the next decade of value creation in the U.S. Advanced Gastroenterology Devices Market.

TABLE OF CONTENT

1. U.S. Advanced Gastroenterology Devices Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Analytical Frameworks & Market Forecasting Models
1.3.6. Data Triangulation, Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Advanced Gastroenterology Device Manufacturers
1.6.2. Endoscope, Imaging and Component Suppliers
1.6.3. Therapeutic Endoscopy Device and Accessory Manufacturers
1.6.4. Hospitals and Integrated Delivery Networks
1.6.5. Gastroenterology Practices and Advanced GI Referral Centers
1.6.6. Ambulatory Surgery Centers and Freestanding Endoscopy Centers
1.6.7. Group Purchasing Organizations, Distributors and Specialty Suppliers
1.6.8. Gastroenterologists, Advanced Endoscopists and Clinical Decision-Makers
1.6.9. Payers, Regulators and Reimbursement Stakeholders

What this section provides: This section establishes the market boundary, device categories, study scope, methodology, assumptions and stakeholder ecosystem used to measure and forecast the U.S. Advanced Gastroenterology Devices Market.

2. U.S. Advanced Gastroenterology Devices Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. Market Size Opportunity, 2025–2035
2.8. High-Growth Technology Opportunity Areas
2.9. High-Growth Clinical Procedure Opportunity Areas
2.10. Leading Regional and State-Level Opportunity Hubs

What this section provides: This section gives decision-makers a concise view of market size, growth trajectory, clinical demand, technology shifts, competitive intensity and high-priority opportunities across the U.S. advanced gastroenterology device ecosystem.

3. U.S. Advanced Gastroenterology Devices Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Rising Burden of Gastrointestinal and Digestive Diseases
3.1.2. Expansion of Colorectal Cancer Screening and Surveillance
3.1.3. Growing Adoption of Minimally Invasive Therapeutic Endoscopy
3.1.4. Rising Demand for Advanced EUS and ERCP Procedures
3.1.5. Increasing Adoption of AI-Assisted Endoscopy and Lesion Detection
3.1.6. Expansion of Ambulatory Gastroenterology and Endoscopy Centers
3.1.7. Growing Obesity and Metabolic Disease Treatment Demand
3.1.8. Hospital Focus on Infection Prevention and Reprocessing Economics
3.2. Restraints and Their Impact Analysis
3.2.1. High Capital Cost of Premium Endoscopy Platforms
3.2.2. Reimbursement Pressure and Value Analysis Scrutiny
3.2.3. Endoscope Reprocessing and Infection-Control Complexity
3.2.4. Advanced Endoscopist and Specialist Workforce Constraints
3.2.5. Product Recall, Device Safety and Quality Risks
3.2.6. Cost Sensitivity Across Ambulatory Endoscopy Facilities
3.3. Opportunities and Their Impact Analysis
3.3.1. AI-Enabled Colorectal Polyp Detection and Characterization
3.3.2. Advanced Endoscopic Tissue Resection and Closure
3.3.3. Interventional Endoscopic Ultrasound Expansion
3.3.4. Endoscopic Bariatric and Metabolic Therapies
3.3.5. Single-Use and Disposable Endoscopy Technologies
3.3.6. Cloud-Enabled Capsule Endoscopy and AI-Assisted Image Review
3.3.7. Robotic and Computer-Assisted Therapeutic Endoscopy
3.3.8. Outpatient Migration of Advanced GI Procedures
3.4. Challenges and Their Impact Analysis
3.4.1. Physician Training and Procedure Learning Curves
3.4.2. Technology Integration Across Existing Endoscopy Installed Bases
3.4.3. Demonstrating Clinical and Economic Value to Hospital Buyers
3.4.4. Supply Chain and Specialized Component Availability
3.4.5. Managing Disposable Device Cost per Procedure
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Clinical Workflow Economics Analysis
3.7. Endoscopy Suite Throughput and Procedure Economics Analysis
3.8. Hospital Capital Procurement Behavior Analysis
3.9. Ambulatory Endoscopy Procurement Economics
3.10. Technology Replacement and Upgrade Cycle Analysis

What this section provides: This section explains the clinical, commercial, reimbursement, procedural and operational forces shaping advanced gastroenterology device demand and helps clients evaluate growth opportunities alongside adoption and execution risks.

4. U.S. Advanced Gastroenterology Devices Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry
4.3. Pricing Trend Analysis by Region, 2025–2035
4.4. Value Chain & Supply Chain Analysis
4.5. Endoscope Installed Base and Replacement Cycle Analysis
4.6. Impact of Digitalization and Connected Endoscopy
4.7. Artificial Intelligence Adoption Landscape
4.8. Application & Innovation Landscape
4.9. FDA Regulatory Framework Analysis
4.10. 510(k), De Novo and PMA Pathway Considerations
4.11. CMS Reimbursement and Coverage Landscape
4.12. Medicare Outpatient and Ambulatory Procedure Economics
4.13. Import/Export Restrictions & Tariff Impact
4.14. Government Cancer Screening and Public Health Initiatives
4.15. Impact of Escalating Geopolitical and Supply Chain Tensions
4.16. Hospital Value Analysis Committee Decision Framework
4.17. Endoscope Reprocessing, Infection Prevention and Sustainability Analysis

What this section provides: This section provides a comprehensive view of regulation, reimbursement, pricing, technology adoption, supply chains, infection prevention, capital replacement cycles and purchasing dynamics influencing the U.S. Advanced Gastroenterology Devices Market.

5. U.S. Advanced Gastroenterology Devices Market – By Product Category

5.1. Overview
5.1.1. Segment Share Analysis, By Product Category, 2025 & 2035 (%)
5.1.2. Advanced Endoscopy and Visualization Systems
5.1.2.1. Video Gastroscopes
5.1.2.2. Video Colonoscopes
5.1.2.3. Therapeutic Endoscopes
5.1.2.4. Endoscopic Ultrasound Systems
5.1.2.5. Endoscopy Processors and Light Sources
5.1.2.6. High-Definition and 4K Visualization Platforms
5.1.2.7. Enhanced Optical Imaging Systems
5.1.3. Therapeutic Endoscopy and Tissue Management Devices
5.1.3.1. Polypectomy Snares
5.1.3.2. Biopsy Forceps and Tissue Acquisition Devices
5.1.3.3. Hemostasis Clips and Devices
5.1.3.4. Endoscopic Suturing Systems
5.1.3.5. Tissue Approximation and Closure Devices
5.1.3.6. Endoscopic Resection Devices
5.1.3.7. Dilation and Retrieval Devices
5.1.3.8. Endoscopic Energy and Ablation Devices
5.1.4. EUS, ERCP and Pancreatobiliary Devices
5.1.4.1. Echoendoscopes
5.1.4.2. EUS Fine-Needle Aspiration Devices
5.1.4.3. EUS Fine-Needle Biopsy Devices
5.1.4.4. ERCP Guidewires
5.1.4.5. Sphincterotomes
5.1.4.6. Stone Extraction Balloons and Baskets
5.1.4.7. Biliary and Pancreatic Stents
5.1.4.8. EUS-Guided Drainage and Access Devices
5.1.5. Capsule and Single-Use Endoscopy Devices
5.1.5.1. Small-Bowel Capsule Endoscopy Systems
5.1.5.2. Capsule Endoscopy Recorders and Readers
5.1.5.3. Capsule Analysis Software
5.1.5.4. Single-Use Gastroscopes
5.1.5.5. Single-Use Specialized Endoscopes
5.1.5.6. Disposable Endoscopy Components
5.1.6. Endoscopic Bariatric, Metabolic and Advanced Closure Devices
5.1.6.1. Endoscopic Suturing Platforms
5.1.6.2. Gastric Remodeling Devices
5.1.6.3. Intragastric Devices
5.1.6.4. Endoluminal Tissue Approximation Systems
5.1.6.5. Endoscopic Anti-Reflux Devices
5.1.6.6. Other Advanced Metabolic Gastroenterology Devices

What this section provides: This section identifies the advanced gastroenterology device categories expected to generate the highest revenue contribution and fastest technology-driven growth through 2035.

6. U.S. Advanced Gastroenterology Devices Market – By Application

6.1. Overview
6.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)
6.1.2. Colorectal Cancer Screening, Polyp Detection and Resection
6.1.2.1. Screening Colonoscopy
6.1.2.2. Surveillance Colonoscopy
6.1.2.3. Polyp Detection and Characterization
6.1.2.4. Polypectomy
6.1.2.5. Endoscopic Mucosal Resection
6.1.2.6. Advanced Colorectal Lesion Management
6.1.3. Upper Gastrointestinal Disease, GERD and Barrett’s Esophagus
6.1.3.1. GERD Diagnosis and Management
6.1.3.2. Barrett’s Esophagus Surveillance
6.1.3.3. Esophageal Stricture Management
6.1.3.4. Upper GI Bleeding Management
6.1.3.5. Upper GI Tumor Detection and Treatment
6.1.3.6. Endoscopic Anti-Reflux Procedures
6.1.4. Pancreatic, Biliary and Hepatobiliary Disorders
6.1.4.1. Gallstone and Bile Duct Stone Management
6.1.4.2. Biliary Stricture Management
6.1.4.3. Pancreatic Disease Diagnosis
6.1.4.4. Pancreatic and Biliary Cancer Evaluation
6.1.4.5. EUS-Guided Tissue Acquisition
6.1.4.6. EUS-Guided Drainage and Intervention
6.1.4.7. ERCP-Based Therapeutic Intervention
6.1.5. Inflammatory Bowel Disease, Small-Bowel Disease and GI Bleeding
6.1.5.1. Crohn’s Disease Assessment
6.1.5.2. Ulcerative Colitis Surveillance
6.1.5.3. Small-Bowel Disease Evaluation
6.1.5.4. Obscure Gastrointestinal Bleeding
6.1.5.5. Capsule Endoscopy Applications
6.1.5.6. Endoscopic Hemostasis
6.1.6. Obesity and Metabolic Gastroenterology
6.1.6.1. Endoscopic Sleeve Gastroplasty
6.1.6.2. Gastric Volume Reduction Procedures
6.1.6.3. Intragastric Interventions
6.1.6.4. Endoscopic Revision Procedures
6.1.6.5. Combination Metabolic Treatment Pathways

What this section provides: This section allows clients to evaluate demand by GI clinical use case and prioritize applications with strong procedure volumes, device intensity, reimbursement relevance and technology adoption potential.

7. U.S. Advanced Gastroenterology Devices Market – By End User

7.1. Overview
7.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
7.1.2. Hospitals and Integrated Health Systems
7.1.2.1. Academic Hospitals
7.1.2.2. Community Hospitals
7.1.2.3. Integrated Delivery Networks
7.1.2.4. Tertiary and Quaternary Referral Hospitals
7.1.3. Ambulatory Surgery Centers
7.1.3.1. Hospital-Affiliated ASCs
7.1.3.2. Independent Gastroenterology ASCs
7.1.3.3. Multispecialty ASCs
7.1.4. Gastroenterology Practices and Freestanding Endoscopy Centers
7.1.4.1. Independent Gastroenterology Practices
7.1.4.2. Consolidated Multisite GI Groups
7.1.4.3. Physician-Owned Endoscopy Centers
7.1.5. Academic Medical Centers and Advanced GI Referral Centers
7.1.5.1. Advanced Therapeutic Endoscopy Centers
7.1.5.2. Pancreaticobiliary Referral Centers
7.1.5.3. Gastrointestinal Cancer Centers
7.1.5.4. Clinical Research and Training Centers
7.1.6. Specialty Clinics and Other Care Settings
7.1.6.1. Bariatric and Metabolic Clinics
7.1.6.2. Pediatric Gastroenterology Centers
7.1.6.3. Specialty Diagnostic Centers
7.1.6.4. Other Outpatient Care Settings

What this section provides: This section determines which healthcare settings and customer groups will drive advanced endoscopy capital investment, therapeutic device utilization and recurring gastroenterology procedure demand.

8. U.S. Advanced Gastroenterology Devices Market – By Technology Type

8.1. Overview
8.1.1. Segment Share Analysis, By Technology Type, 2025 & 2035 (%)
8.1.2. HD, 4K and Advanced Optical Imaging
8.1.2.1. High-Definition Endoscopy
8.1.2.2. 4K Endoscopy
8.1.2.3. Electronic Chromoendoscopy
8.1.2.4. Narrow-Band and Wavelength-Specific Imaging
8.1.2.5. Advanced Mucosal Visualization Technologies
8.1.3. Artificial Intelligence and Software-Assisted Endoscopy
8.1.3.1. Computer-Aided Detection
8.1.3.2. Computer-Aided Diagnosis and Characterization
8.1.3.3. AI-Assisted Capsule Endoscopy
8.1.3.4. Automated Procedure Documentation
8.1.3.5. Endoscopy Quality Analytics
8.1.3.6. Cloud-Based Endoscopy Workflow Platforms
8.1.4. Robotic, Navigational and Computer-Assisted Endoscopy
8.1.4.1. Robotic Endoluminal Platforms
8.1.4.2. Computer-Assisted Therapeutic Endoscopy
8.1.4.3. Navigation and Scope Guidance Technologies
8.1.4.4. Emerging Robotic GI Intervention Platforms
8.1.5. Single-Use and Disposable Technology
8.1.5.1. Single-Use Endoscopes
8.1.5.2. Disposable Endoscope Components
8.1.5.3. Disposable Therapeutic Accessories
8.1.5.4. Infection-Control-Oriented Single-Use Platforms
8.1.6. Advanced Energy, Suturing, Closure and Tissue-Resection Technology
8.1.6.1. Advanced Electrosurgical Devices
8.1.6.2. Endoscopic Ablation Systems
8.1.6.3. Endoscopic Suturing Technology
8.1.6.4. Mechanical Closure Technology
8.1.6.5. Endoscopic Mucosal Resection Technology
8.1.6.6. Endoscopic Submucosal Dissection Technology

What this section provides: This section evaluates the core technologies transforming gastrointestinal diagnosis and therapy, including advanced imaging, AI, robotics, single-use endoscopy, tissue resection, suturing and closure platforms.

9. U.S. Advanced Gastroenterology Devices Market – By Procurement Channel

9.1. Overview
9.1.1. Segment Share Analysis, By Procurement Channel, 2025 & 2035 (%)
9.1.2. Direct Hospital and Health System Procurement
9.1.2.1. Capital Equipment Purchases
9.1.2.2. Therapeutic Device and Consumable Contracts
9.1.2.3. Service and Maintenance Agreements
9.1.3. Integrated Delivery Network Enterprise Contracts
9.1.3.1. Multihospital Standardization Agreements
9.1.3.2. Enterprise Endoscopy Platform Contracts
9.1.3.3. Bundled Capital and Consumable Contracts
9.1.4. Group Purchasing Organization Contracts
9.1.4.1. National GPO Agreements
9.1.4.2. Regional Purchasing Networks
9.1.4.3. Committed and Non-Committed Contract Models
9.1.5. Distributor and Specialty Supplier Sales
9.1.5.1. National Medical Device Distributors
9.1.5.2. Specialty Endoscopy Distributors
9.1.5.3. Procedure-Specific Accessory Distribution
9.1.6. Ambulatory and Gastroenterology Practice Procurement
9.1.6.1. ASC Direct Purchasing
9.1.6.2. Independent GI Practice Procurement
9.1.6.3. Multisite Gastroenterology Group Contracts
9.1.6.4. Physician-Owned Endoscopy Center Procurement

What this section provides: This section explains how advanced gastroenterology devices are purchased across U.S. hospitals, IDNs, GPOs, ambulatory centers and GI practices, helping clients understand contracting power, vendor standardization and route-to-market dynamics.

10. U.S. Advanced Gastroenterology Devices Market – By Geography
10.1. Introduction

10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Gastroenterology Procedure Volume Analysis
10.1.4. Regional Hospital, ASC and Endoscopy Infrastructure Analysis
10.1.5. Regional Advanced Endoscopist and Referral Center Analysis
10.1.6. Regional Reimbursement and Procurement Dynamics
10.1.7. Regional AI and Advanced Endoscopy Adoption Analysis

10.2. West Region

10.2.1. Regional Overview & Trends
10.2.2. West Region Advanced Gastroenterology Device Key Manufacturers and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.9. California

10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.10. Washington

10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.11. Arizona

10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.12. Colorado

10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.13. Oregon

10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.14. Utah

10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.15. Nevada

10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.16. New Mexico

10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.17. Idaho

10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.18. Montana

10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.19. Wyoming

10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.20. Alaska

10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.21. Hawaii

10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3. Northeast Region

10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Advanced Gastroenterology Device Key Manufacturers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.9. New York

10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.10. Massachusetts

10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.11. New Jersey

10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.12. Pennsylvania

10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.13. Connecticut

10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.14. Maine

10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.15. Vermont

10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.16. New Hampshire

10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.17. Rhode Island

10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.18. Delaware

10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4. South Region

10.4.1. Regional Overview & Trends
10.4.2. South Region Advanced Gastroenterology Device Key Manufacturers and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.9. Texas

10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.10. Florida

10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.11. Georgia

10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.12. North Carolina

10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.13. Tennessee

10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.14. South Carolina

10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.15. Alabama

10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.16. Mississippi

10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.17. Louisiana

10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.18. Arkansas

10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.19. Kentucky

10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.20. Oklahoma

10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.21. Virginia

10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.22. Maryland

10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.23. West Virginia

10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5. Midwest Region

10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Advanced Gastroenterology Device Key Manufacturers and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.9. Illinois

10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.10. Ohio

10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.11. Michigan

10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.12. Minnesota

10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.13. Indiana

10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.14. Wisconsin

10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.15. Missouri

10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.16. Iowa

10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.17. Kansas

10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.18. Nebraska

10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.19. North Dakota

10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.20. South Dakota

10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

What this section provides: This section delivers comprehensive regional and state-level market intelligence across all 50 states, allowing clients to identify advanced-endoscopy adoption hubs, major procedure-volume markets, hospital and ASC opportunity clusters, technology hotspots and state-level commercial priorities.

11. U.S. Advanced Gastroenterology Devices Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Company Positioning Matrix
11.2.1. Market Leaders
11.2.2. Established Challengers
11.2.3. Technology Innovators
11.2.4. Emerging and Specialized Players
11.3. Company Profiles
11.3.1. Olympus Corporation
11.3.2. Boston Scientific Corporation
11.3.3. Medtronic
11.3.4. FUJIFILM Healthcare Americas Corporation
11.3.5. PENTAX Medical / HOYA Corporation
11.3.6. STERIS
11.3.7. Cook Medical
11.3.8. CONMED Corporation
11.3.9. Ambu A/S
11.3.10. KARL STORZ
11.3.11. ERBE USA
11.3.12. B. Braun
11.3.13. Micro-Tech Endoscopy USA
11.3.14. Ovesco Endoscopy USA
11.3.15. Merit Medical Systems
11.3.16. EvoEndo
11.3.17. EndoGastric Solutions
11.3.18. CapsoVision
11.3.19. AnX Robotica
11.3.20. Creo Medical
11.3.21. Laborie Medical Technologies
11.3.22. Endo Tools Therapeutics
11.3.23. Cosmo Pharmaceuticals / Cosmo Intelligent Medical Devices
11.3.24. Envision Endoscopy
11.3.25. Apollo Endosurgery / Boston Scientific

11.4. Competitive Benchmarking by Product Portfolio
11.5. Competitive Benchmarking by Advanced Endoscopy Technology
11.6. Competitive Benchmarking by U.S. Commercial Footprint
11.7. Strategic Partnerships, Acquisitions and Portfolio Expansion
11.8. FDA Pipeline and Innovation Positioning
11.9. Physician Training and Clinical Education Strategies

Note: Each company profile will include company overview, advanced gastroenterology device portfolio, U.S. market strategy, financial positioning, innovation pipeline, regulatory updates, clinical evidence, partnerships, acquisitions and recent developments.

What this section provides: This section provides competitor benchmarking, market-share visibility, portfolio positioning, clinical innovation direction and strategic intelligence on major companies shaping the U.S. Advanced Gastroenterology Devices Market.

12. U.S. Advanced Gastroenterology Devices Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technologies Impact
12.2.1. AI-Assisted Polyp Detection and Characterization
12.2.2. AI-Enabled Capsule Endoscopy
12.2.3. Interventional Endoscopic Ultrasound
12.2.4. Advanced Endoscopic Suturing and Closure
12.2.5. Robotic and Computer-Assisted Endoscopy
12.2.6. Single-Use Endoscopy Platforms
12.2.7. Advanced Optical and Molecular Imaging
12.2.8. Endoscopic Bariatric and Metabolic Intervention
12.3. Shift from Diagnostic to Therapeutic Endoscopy
12.4. Impact of Outpatient Procedure Migration
12.5. Impact of GI Practice Consolidation
12.6. Emerging Business and Revenue Models
12.7. Business Opportunities for Startups and Existing Players
12.8. Investment Prioritization Matrix
12.9. Technology Adoption Curve, 2026–2035
12.10. Long-Term Procedure and Installed-Base Outlook

What this section provides: This section prepares clients for future technology disruption, procedure migration, changing care models, investment opportunities and potential market-adoption scenarios through 2035.

13. U.S. Advanced Gastroenterology Devices Market: Strategic Recommendations

13.1. Recommendations for Advanced Gastroenterology Device Manufacturers
13.2. Recommendations for Endoscopy Platform Manufacturers
13.3. Recommendations for Hospitals and Integrated Health Systems
13.4. Recommendations for Gastroenterology Practices and ASC Operators
13.5. Recommendations for Investors and Private Equity Firms
13.6. Recommendations for Distributors and Channel Partners
13.7. Recommendations for New Entrants and Startups
13.8. U.S. Go-to-Market Strategy Considerations
13.9. Hospital and IDN Contracting Strategy
13.10. Ambulatory Endoscopy Commercialization Strategy
13.11. Physician Education and KOL Engagement Strategy
13.12. Product Positioning and Portfolio Expansion Guidance
13.13. AI and Digital Endoscopy Commercialization Strategy
13.14. M&A and Strategic Partnership Opportunity Assessment

What this section provides: This section converts market intelligence into actionable recommendations for market entry, product positioning, hospital and ASC penetration, channel expansion, portfolio development, investment decisions and competitive differentiation.

14. U.S. Advanced Gastroenterology Devices Market: Disclaimer

14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Market Definition and Product Inclusion Limitation
14.4. Forecasting Limitation
14.5. State-Level Estimation Limitation
14.6. Legal Disclaimer
14.7. Third-Party Data Disclaimer
14.8. Regulatory and Reimbursement Information Disclaimer

What this section provides: This section defines the report’s analytical limitations, market-estimation boundaries, state-level forecasting considerations, legal conditions, third-party data limitations and assumptions associated with regulatory and reimbursement analysis.

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Advanced Gastroenterology Devices Market: Market Definition and Scope
TABLE 3: U.S. Advanced Gastroenterology Devices Market: Research Methodology Framework
TABLE 4: U.S. Advanced Gastroenterology Devices Market: Key Assumptions
TABLE 5: U.S. Advanced Gastroenterology Devices Market: Market Ecosystem Overview
TABLE 6: U.S. Advanced Gastroenterology Devices Market: Stakeholder Analysis
TABLE 7: U.S. Advanced Gastroenterology Devices Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Advanced Gastroenterology Devices Market: Analyst Viewpoint Summary
TABLE 9: U.S. Advanced Gastroenterology Devices Market: Market Attractiveness Index
TABLE 10: U.S. Advanced Gastroenterology Devices Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Advanced Gastroenterology Devices Market: Base Year Market Positioning, 2025
TABLE 12: U.S. Advanced Gastroenterology Devices Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 13: U.S. Advanced Gastroenterology Devices Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 14: U.S. Advanced Gastroenterology Devices Market: High-Growth Opportunity Areas
TABLE 15: U.S. Advanced Gastroenterology Devices Market: Drivers; Impact Analysis
TABLE 16: U.S. Advanced Gastroenterology Devices Market: Restraints; Impact Analysis
TABLE 17: U.S. Advanced Gastroenterology Devices Market: Opportunities; Impact Analysis
TABLE 18: U.S. Advanced Gastroenterology Devices Market: Challenges; Impact Analysis
TABLE 19: U.S. Advanced Gastroenterology Devices Market: Patent & Innovation Analysis, 2021–2025
TABLE 20: U.S. Advanced Gastroenterology Devices Market: Clinical Workflow Economics Matrix
TABLE 21: U.S. Advanced Gastroenterology Devices Market: Endoscopy Suite Throughput Economics
TABLE 22: U.S. Advanced Gastroenterology Devices Market: Hospital Capital Procurement Behavior Matrix
TABLE 23: U.S. Advanced Gastroenterology Devices Market: Ambulatory Endoscopy Procurement Economics
TABLE 24: U.S. Advanced Gastroenterology Devices Market: Technology Replacement & Upgrade Cycle Analysis
TABLE 25: U.S. Advanced Gastroenterology Devices Market: PESTEL Analysis
TABLE 26: U.S. Advanced Gastroenterology Devices Market: Porter’s Five Forces Analysis
TABLE 27: U.S. Advanced Gastroenterology Devices Market: Pricing Trend Analysis by Region, 2025–2035
TABLE 28: U.S. Advanced Gastroenterology Devices Market: Value Chain Analysis
TABLE 29: U.S. Advanced Gastroenterology Devices Market: Supply Chain Analysis
TABLE 30: U.S. Advanced Gastroenterology Devices Market: Endoscope Installed Base & Replacement Cycle Analysis
TABLE 31: U.S. Advanced Gastroenterology Devices Market: Digitalization and Connected Endoscopy Impact
TABLE 32: U.S. Advanced Gastroenterology Devices Market: Artificial Intelligence Adoption Landscape
TABLE 33: U.S. Advanced Gastroenterology Devices Market: Application & Innovation Landscape
TABLE 34: U.S. Advanced Gastroenterology Devices Market: FDA Regulatory Framework Analysis
TABLE 35: U.S. Advanced Gastroenterology Devices Market: 510(k), De Novo & PMA Pathway Analysis
TABLE 36: U.S. Advanced Gastroenterology Devices Market: CMS Reimbursement & Coverage Landscape
TABLE 37: U.S. Advanced Gastroenterology Devices Market: Medicare Outpatient & ASC Procedure Economics
TABLE 38: U.S. Advanced Gastroenterology Devices Market: Import/Export Restrictions & Tariff Impact
TABLE 39: U.S. Advanced Gastroenterology Devices Market: Hospital Value Analysis Committee Decision Framework
TABLE 40: U.S. Advanced Gastroenterology Devices Market: Product Category Snapshot, 2025
TABLE 41: Segment Dashboard; Definition and Scope, by Product Category
TABLE 42: U.S. Advanced Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 43: U.S. Advanced Gastroenterology Devices Market: Segment Share Analysis, by Product Category, 2025 & 2035 (%)
TABLE 44: Advanced Endoscopy and Visualization Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 45: Therapeutic Endoscopy and Tissue Management Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 46: EUS, ERCP and Pancreatobiliary Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 47: Capsule and Single-Use Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 48: Endoscopic Bariatric, Metabolic and Advanced Closure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 49: U.S. Advanced Gastroenterology Devices Market: Application Snapshot, 2025
TABLE 50: Segment Dashboard; Definition and Scope, by Application
TABLE 51: U.S. Advanced Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 52: U.S. Advanced Gastroenterology Devices Market: Segment Share Analysis, by Application, 2025 & 2035 (%)
TABLE 53: Colorectal Cancer Screening, Polyp Detection and Resection Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 54: Upper Gastrointestinal Disease, GERD and Barrett’s Esophagus Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 55: Pancreatic, Biliary and Hepatobiliary Disorders Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 56: Inflammatory Bowel Disease, Small-Bowel Disease and GI Bleeding Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 57: Obesity and Metabolic Gastroenterology Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 58: U.S. Advanced Gastroenterology Devices Market: End User Snapshot, 2025
TABLE 59: Segment Dashboard; Definition and Scope, by End User
TABLE 60: U.S. Advanced Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 61: U.S. Advanced Gastroenterology Devices Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 62: Hospitals and Integrated Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 63: Ambulatory Surgery Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 64: Gastroenterology Practices and Freestanding Endoscopy Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 65: Academic Medical Centers and Advanced GI Referral Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 66: Specialty Clinics and Other Care Settings Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 67: U.S. Advanced Gastroenterology Devices Market: Technology Type Snapshot, 2025
TABLE 68: Segment Dashboard; Definition and Scope, by Technology Type
TABLE 69: U.S. Advanced Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 70: U.S. Advanced Gastroenterology Devices Market: Segment Share Analysis, by Technology Type, 2025 & 2035 (%)
TABLE 71: HD, 4K and Advanced Optical Imaging Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 72: Artificial Intelligence and Software-Assisted Endoscopy Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 73: Robotic, Navigational and Computer-Assisted Endoscopy Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 74: Single-Use and Disposable Technology Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 75: Advanced Energy, Suturing, Closure and Tissue-Resection Technology Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 76: U.S. Advanced Gastroenterology Devices Market: Procurement Channel Snapshot, 2025
TABLE 77: Segment Dashboard; Definition and Scope, by Procurement Channel
TABLE 78: U.S. Advanced Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 79: U.S. Advanced Gastroenterology Devices Market: Segment Share Analysis, by Procurement Channel, 2025 & 2035 (%)
TABLE 80: Direct Hospital and Health System Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 81: Integrated Delivery Network Enterprise Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 82: Group Purchasing Organization Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 83: Distributor and Specialty Supplier Sales Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 84: Ambulatory and Gastroenterology Practice Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 85: U.S. Advanced Gastroenterology Devices Market: Regional Snapshot, 2025
TABLE 86: Segment Dashboard; Definition and Scope, by Geography
TABLE 87: U.S. Advanced Gastroenterology Devices Market, by Region, 2021–2035 (US$ Billion)
TABLE 88: U.S. Advanced Gastroenterology Devices Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 89: U.S. Advanced Gastroenterology Devices Market: Regional Gastroenterology Procedure Volume Analysis
TABLE 90: U.S. Advanced Gastroenterology Devices Market: Regional Hospital, ASC and Endoscopy Infrastructure Analysis
TABLE 91: West Region U.S. Advanced Gastroenterology Devices Market: Regional Overview and Trends
TABLE 92: West Region U.S. Advanced Gastroenterology Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 93: West Region U.S. Advanced Gastroenterology Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 94: West Region U.S. Advanced Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 95: West Region U.S. Advanced Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 96: West Region U.S. Advanced Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 97: West Region U.S. Advanced Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 98: West Region U.S. Advanced Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 99: California Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 100: Washington Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 101: Arizona Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 102: Colorado Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 103: Oregon Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 104: Utah Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 105: Nevada Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 106: New Mexico Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 107: Idaho Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 108: Montana Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 109: Wyoming Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 110: Alaska Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 111: Hawaii Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 112: Northeast Region U.S. Advanced Gastroenterology Devices Market: Regional Overview and Trends
TABLE 113: Northeast Region U.S. Advanced Gastroenterology Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 114: Northeast Region U.S. Advanced Gastroenterology Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 115: Northeast Region U.S. Advanced Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 116: Northeast Region U.S. Advanced Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 117: Northeast Region U.S. Advanced Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 118: Northeast Region U.S. Advanced Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 119: Northeast Region U.S. Advanced Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 120: New York Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 121: Massachusetts Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 122: New Jersey Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 123: Pennsylvania Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 124: Connecticut Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 125: Maine Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 126: Vermont Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 127: New Hampshire Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 128: Rhode Island Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 129: Delaware Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 130: South Region U.S. Advanced Gastroenterology Devices Market: Regional Overview and Trends
TABLE 131: South Region U.S. Advanced Gastroenterology Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 132: South Region U.S. Advanced Gastroenterology Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 133: South Region U.S. Advanced Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 134: South Region U.S. Advanced Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 135: South Region U.S. Advanced Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 136: South Region U.S. Advanced Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 137: South Region U.S. Advanced Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 138: Texas Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 139: Florida Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 140: Georgia Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 141: North Carolina Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 142: Tennessee Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 143: South Carolina Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 144: Alabama Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 145: Mississippi Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 146: Louisiana Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 147: Arkansas Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 148: Kentucky Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 149: Oklahoma Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 150: Virginia Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 151: Maryland Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 152: West Virginia Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 153: Midwest Region U.S. Advanced Gastroenterology Devices Market: Regional Overview and Trends
TABLE 154: Midwest Region U.S. Advanced Gastroenterology Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 155: Midwest Region U.S. Advanced Gastroenterology Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 156: Midwest Region U.S. Advanced Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 157: Midwest Region U.S. Advanced Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 158: Midwest Region U.S. Advanced Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 159: Midwest Region U.S. Advanced Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 160: Midwest Region U.S. Advanced Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 161: Illinois Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 162: Ohio Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 163: Michigan Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 164: Minnesota Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 165: Indiana Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 166: Wisconsin Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 167: Missouri Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 168: Iowa Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 169: Kansas Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 170: Nebraska Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 171: North Dakota Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 172: South Dakota Advanced Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 173: U.S. Advanced Gastroenterology Devices Market: Competitive Landscape Snapshot, 2025
TABLE 174: U.S. Advanced Gastroenterology Devices Market: Key Company Market Share Analysis, 2025
TABLE 175: U.S. Advanced Gastroenterology Devices Market: Company Positioning Matrix
TABLE 176: U.S. Advanced Gastroenterology Devices Market: Product Portfolio Benchmarking of Key Players
TABLE 177: U.S. Advanced Gastroenterology Devices Market: Advanced Endoscopy Technology Benchmarking
TABLE 178: U.S. Advanced Gastroenterology Devices Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 179: Olympus Corporation: Company Profile
TABLE 180: Boston Scientific Corporation: Company Profile
TABLE 181: Medtronic: Company Profile
TABLE 182: FUJIFILM Healthcare Americas Corporation: Company Profile
TABLE 183: PENTAX Medical / HOYA Corporation: Company Profile
TABLE 184: STERIS: Company Profile
TABLE 185: Cook Medical: Company Profile
TABLE 186: CONMED Corporation: Company Profile
TABLE 187: Ambu A/S: Company Profile
TABLE 188: KARL STORZ: Company Profile
TABLE 189: ERBE USA: Company Profile
TABLE 190: B. Braun: Company Profile
TABLE 191: Micro-Tech Endoscopy USA: Company Profile
TABLE 192: Ovesco Endoscopy USA: Company Profile
TABLE 193: Merit Medical Systems: Company Profile
TABLE 194: EvoEndo: Company Profile
TABLE 195: EndoGastric Solutions: Company Profile
TABLE 196: CapsoVision: Company Profile
TABLE 197: AnX Robotica: Company Profile
TABLE 198: Creo Medical: Company Profile
TABLE 199: Laborie Medical Technologies: Company Profile
TABLE 200: Endo Tools Therapeutics: Company Profile
TABLE 201: Cosmo Pharmaceuticals / Cosmo Intelligent Medical Devices: Company Profile
TABLE 202: Envision Endoscopy: Company Profile
TABLE 203: Apollo Endosurgery / Boston Scientific: Company Profile
TABLE 204: U.S. Advanced Gastroenterology Devices Market: Future Market Scenario Analysis, 2026–2035
TABLE 205: U.S. Advanced Gastroenterology Devices Market: Disruptive Technologies Impact Matrix
TABLE 206: U.S. Advanced Gastroenterology Devices Market: Technology Adoption Curve, 2026–2035
TABLE 207: U.S. Advanced Gastroenterology Devices Market: Emerging Business Trends
TABLE 208: U.S. Advanced Gastroenterology Devices Market: Business Opportunities for Startups and Existing Players
TABLE 209: U.S. Advanced Gastroenterology Devices Market: Investment Prioritization Matrix
TABLE 210: U.S. Advanced Gastroenterology Devices Market: Strategic Recommendations for Device Manufacturers
TABLE 211: U.S. Advanced Gastroenterology Devices Market: Strategic Recommendations for Hospitals and Integrated Health Systems
TABLE 212: U.S. Advanced Gastroenterology Devices Market: Strategic Recommendations for Gastroenterology Practices and ASCs
TABLE 213: U.S. Advanced Gastroenterology Devices Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 214: U.S. Advanced Gastroenterology Devices Market: Strategic Recommendations for Distributors and Channel Partners
TABLE 215: U.S. Advanced Gastroenterology Devices Market: Strategic Recommendations for New Entrants and Startups
TABLE 216: U.S. Advanced Gastroenterology Devices Market: U.S. Go-to-Market Strategy Considerations
TABLE 217: U.S. Advanced Gastroenterology Devices Market: Product Positioning and Portfolio Expansion Guidance
TABLE 218: U.S. Advanced Gastroenterology Devices Market: AI and Digital Endoscopy Commercialization Strategy
TABLE 219: U.S. Advanced Gastroenterology Devices Market: Scope Limitation
TABLE 220: U.S. Advanced Gastroenterology Devices Market: Data Use Limitation
TABLE 221: U.S. Advanced Gastroenterology Devices Market: Market Definition and Forecasting Limitation
TABLE 222: U.S. Advanced Gastroenterology Devices Market: State-Level Estimation Limitation
TABLE 223: U.S. Advanced Gastroenterology Devices Market: Legal and Third-Party Data Disclaimer
TABLE 224: U.S. Advanced Gastroenterology Devices Market: Regulatory and Reimbursement Information Disclaimer

List of Figures

FIGURE 1: U.S. Advanced Gastroenterology Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: U.S. Advanced Gastroenterology Devices Market Ecosystem
FIGURE 4: U.S. Advanced Gastroenterology Devices Market Stakeholder Framework
FIGURE 5: U.S. Advanced Gastroenterology Devices Market Executive Snapshot, 2025
FIGURE 6: Market Attractiveness Analysis
FIGURE 7: U.S. Advanced Gastroenterology Devices Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 8: U.S. Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 9: U.S. Advanced Gastroenterology Devices Market Year-wise Growth Curve, 2021–2035
FIGURE 10: High-Growth Opportunity Map, 2026–2035
FIGURE 11: Market Dynamics
FIGURE 12: Innovation & Patent Landscape, 2021–2025
FIGURE 13: Clinical Workflow Economics Framework
FIGURE 14: Endoscopy Suite Throughput Economics Framework
FIGURE 15: Hospital Capital Procurement Decision Framework
FIGURE 16: Ambulatory Endoscopy Procurement Framework
FIGURE 17: Technology Replacement and Upgrade Cycle
FIGURE 18: PESTEL Analysis
FIGURE 19: Porter’s Five Forces Analysis
FIGURE 20: Value Chain Analysis
FIGURE 21: Supply Chain Analysis
FIGURE 22: Advanced Endoscopy Installed Base and Replacement Cycle
FIGURE 23: AI and Connected Endoscopy Adoption Landscape
FIGURE 24: FDA Regulatory and Market Access Framework
FIGURE 25: CMS Reimbursement and Procedure Economics Framework
FIGURE 26: Product Category Segment Market Share Analysis, 2025 & 2035
FIGURE 27: Product Category Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 28: Advanced Endoscopy and Visualization Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 29: Therapeutic Endoscopy and Tissue Management Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 30: EUS, ERCP and Pancreatobiliary Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 31: Capsule and Single-Use Endoscopy Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 32: Endoscopic Bariatric, Metabolic and Advanced Closure Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 33: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 34: Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 35: Colorectal Cancer Screening, Polyp Detection and Resection Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 36: Upper GI Disease, GERD and Barrett’s Esophagus Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 37: Pancreatic, Biliary and Hepatobiliary Disorders Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 38: IBD, Small-Bowel Disease and GI Bleeding Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 39: Obesity and Metabolic Gastroenterology Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 40: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 41: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 42: Hospitals and Integrated Health Systems Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 43: Ambulatory Surgery Centers Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 44: Gastroenterology Practices and Freestanding Endoscopy Centers Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 45: Academic Medical Centers and Advanced GI Referral Centers Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 46: Specialty Clinics and Other Care Settings Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 47: Technology Type Segment Market Share Analysis, 2025 & 2035
FIGURE 48: Technology Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 49: HD, 4K and Advanced Optical Imaging Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 50: AI and Software-Assisted Endoscopy Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 51: Robotic, Navigational and Computer-Assisted Endoscopy Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 52: Single-Use and Disposable Technology Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 53: Advanced Energy, Suturing, Closure and Tissue-Resection Technology Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 54: Procurement Channel Segment Market Share Analysis, 2025 & 2035
FIGURE 55: Procurement Channel Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 56: Direct Hospital and Health System Procurement Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 57: Integrated Delivery Network Enterprise Contracts Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 58: Group Purchasing Organization Contracts Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 59: Distributor and Specialty Supplier Sales Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 60: Ambulatory and Gastroenterology Practice Procurement Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 61: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 62: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 63: Regional Gastroenterology Procedure Volume and Endoscopy Infrastructure Map
FIGURE 64: West Region U.S. Advanced Gastroenterology Devices Market Share and Leading Players, 2025
FIGURE 65: West Region Market Share Analysis by State, 2025
FIGURE 66: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 67: California Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 68: Washington Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 69: Arizona Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 70: Colorado Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 71: Oregon Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 72: Utah Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 73: Nevada Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 74: New Mexico Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 75: Idaho Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 76: Montana Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 77: Wyoming Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 78: Alaska Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 79: Hawaii Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 80: Northeast Region U.S. Advanced Gastroenterology Devices Market Share and Leading Players, 2025
FIGURE 81: Northeast Region Market Share Analysis by State, 2025
FIGURE 82: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 83: New York Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 84: Massachusetts Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 85: New Jersey Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 86: Pennsylvania Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 87: Connecticut Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 88: Maine Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 89: Vermont Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 90: New Hampshire Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 91: Rhode Island Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 92: Delaware Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 93: South Region U.S. Advanced Gastroenterology Devices Market Share and Leading Players, 2025
FIGURE 94: South Region Market Share Analysis by State, 2025
FIGURE 95: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: Texas Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 97: Florida Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 98: Georgia Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 99: North Carolina Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 100: Tennessee Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 101: South Carolina Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 102: Alabama Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 103: Mississippi Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 104: Louisiana Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 105: Arkansas Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 106: Kentucky Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 107: Oklahoma Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 108: Virginia Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 109: Maryland Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 110: West Virginia Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 111: Midwest Region U.S. Advanced Gastroenterology Devices Market Share and Leading Players, 2025
FIGURE 112: Midwest Region Market Share Analysis by State, 2025
FIGURE 113: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 114: Illinois Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 115: Ohio Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 116: Michigan Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 117: Minnesota Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 118: Indiana Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 119: Wisconsin Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 120: Missouri Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 121: Iowa Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 122: Kansas Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 123: Nebraska Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 124: North Dakota Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 125: South Dakota Advanced Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 126: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 127: Company Positioning Matrix
FIGURE 128: Key Player Product Portfolio Benchmarking
FIGURE 129: Advanced Endoscopy Technology Competitive Benchmarking
FIGURE 130: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 131: U.S. Advanced Gastroenterology Devices Innovation Roadmap
FIGURE 132: AI-Assisted Endoscopy Adoption Roadmap
FIGURE 133: Interventional EUS and ERCP Technology Opportunity Map
FIGURE 134: Advanced Suturing, Closure and Tissue Resection Growth Roadmap
FIGURE 135: Single-Use Endoscopy Adoption Roadmap
FIGURE 136: Robotic and Computer-Assisted Endoscopy Opportunity Map
FIGURE 137: Future Market Scenario Analysis, 2026–2035
FIGURE 138: Disruptive Technologies Impact Matrix
FIGURE 139: Technology Adoption Curve, 2026–2035
FIGURE 140: Emerging Business Trends Matrix
FIGURE 141: Investment Prioritization Matrix
FIGURE 142: Strategic Growth Roadmap for U.S. Advanced Gastroenterology Device Companies
FIGURE 143: Hospital and IDN Go-to-Market Strategy Framework
FIGURE 144: Ambulatory Endoscopy Commercialization Framework
FIGURE 145: Product Positioning and Portfolio Expansion Framework
FIGURE 146: AI and Digital Endoscopy Commercialization Roadmap
FIGURE 147: Report Scope, Forecasting and Disclaimer Framework